Wake up daily to our latest coverage of business done better, directly in your inbox.


Get your weekly dose of analysis on rising corporate activism.


The best of solutions journalism in the sustainability space, published monthly.

Select Newsletter

By signing up you agree to our privacy policy. You can opt out anytime.

CSR in 2016: Who Was Naughty and Who Was Nice

By 3p Contributor

By Dale Wannen

With the close of 2016 approaching, it’s that time again where we can sit back and think about what an “interesting” year it has been. In fact, just the news of Brexit and the rather surprising election results would have been plenty to sit and ponder over some spiked egg nog. But if you still have an appetite, check out our naughty and nice corporate scandals to bring lively conversation to the holiday party.


1. We all can’t stand paying that $3 ATM fee. But imagine paying fees on an account you didn't even sign up for. Wells Fargo was caught opening over 1.5 million accounts that were not authorized. Wells also fired 5,300 employees related to the shady behavior. Since the scandal, CEO John Stumpf (who agreed to not receive the $41 million in unvested options — thanks!) has stepped down from both the CEO role and chairman of the board. New customer checking account openings plunged 41 percent in November compared with last year. Note that Wells has stated the CEO can no longer also be the chairman of the board, clearly a rule that could have helped the company avoid this mess.

2. Increasing the price of a service or good by over 600 percent would generally cause the buyer to simply stop buying. But when the convoluted world of pharmaceuticals is involved, it seems to be the norm. Enter the Epipen and Mylan Pharmaceutical CEO Heather Bresch. As Bresch spiked the cost of the EpiPen, which is used to help children who experience allergic reactions, her own compensation increased 671 percent -- from about $2.5 million in 2007, to some $18.9 million in 2015. Mylan agreed to fork over $465 million to make up for years of underpaid Medicaid rebates on the product. The company is also in the midst of laying off about 10 percent of its workforce.

3. Got a friend at JPMorgan? JPMorgan Chase & Co. will pay $264 million to the U.S. government to settle allegations that it hired the children and relatives of influential Chinese policymakers in the hope of winning their business. The settlement follows a three-year investigation. The practice of giving the children of China's ruling class plum jobs was so common that the bank had a formal program known as "Sons and Daughters." The program included spreadsheets that tracked how often the hires turned into business deals. Somehow CEO Jamie Dimon still has a job and is now a member of President-elect Donald Trump’s economic advisory team.

4. The big pharmas sure know how to pay themselves. This final spot goes to Leonard Schleifer of Regeneron Pharmaceuticals. He netted about $47 million, up from $42 million last year. To put that in perspective: With a five-day, 40-hour work week, Schleifer would make more than $22,800 an hour; $182,000 a day; and $910,000 a week. As of Dec. 19, the stock’s year-to-date performance was negative 30 percent. Yes, that’s negative. Something tells me that Regeneron’s compensation package needs some tweaking.


1. We have all heard of the evil oil-congested Carbon Underground 200, but what about the good guys? Nonprofits As You Sow and Corporate Knights came up with the flipside version called the Clean 200. And the winner is Toyota! Companies eligible for the Clean 200 must have a market capitalization of at least $1 billion and derive at least 10 percent of their revenue from clean energy as defined by Bloomberg New Energy Finance (BNEF). Second to Toyota was Siemens, while Johnson Controls came in third.

2. Patagonia donates all Black Friday profits to environmental charities. Can you top that!? The apparel company donated $10 million in Black Friday sales to charity. Instead of donating to just one charity, however, Patagonia will give money to "hundreds of grassroots environmental organizations." The activewear company only projected $2 million in sales and said it was "humbled" by the final figure. Patagonia is not a publicly-traded stock. Shucks.

3. Take that United States! At 648 megawatts, India and the Adani Group have opened the largest solar plant in the world. The plant will power 150,000 homes and is a step closer to making the country fully sustainable. Facing a growing population, India’s goal is to produce 40 percent of its energy through renewable resources by 2030. The world's second largest solar plant, the Topaz Solar Farm in San Luis Obispo County, California, has a capacity of 550 megawatts. Do I sense a little friendly alternative energy competition to build the first 1,000-megawatt station?

4. How about a positive note for the big pharmas? Fortune Magazine unveiled its 2016 “Change the World” roster of 50 companies which focused on social and environmental challenges. Topping the list is pharma firm GlaxoSmithKline, which bases drug prices on income levels in the countries where it operates and reinvests 20 percent of any profits it makes in the least developed countries into training health workers and building medical infrastructure. On top of this, its CEO made a fraction of what the aforementioned drug-pushing CEOs made.

Image credit: Flickr/Mobilus In Mobili

Dale Wannen is President of Sustainvest Asset Management, an investment advisory firm focused on sustainable and responsible investing (SRI).

TriplePundit has published articles from over 1000 contributors. If you'd like to be a guest author, please get in touch!

Read more stories by 3p Contributor